2017 Emerging Leader in Chromatography Call for Nominations
Nominate a colleague or yourself for the 2017 LCGC Emerging Leader in Chromatography Award
Submission Deadline Extended: November 16, 2015
LCGC North America
is seeking nominations for the 10th Annual Emerging Leader in Chromatography award, to be awarded in 2017. The Emerging Leader award recognizes the achievements and aspirations of a talented young separation scientist who has made strides early in his or her career toward the advancement of chromatographic techniques and applications. The winner will be featured on the cover of a 2017 issue of
LCGC
and in an interview that will be featured in our electronic newsletter, e-Separation Solutions, and on the
LCGC
website.
CRITERIA
Candidates for the
LCGC
Emerging Leader in Chromatography award must work in the field of separation science. In 2017, candidates must be within 10 years of receiving their highest degree, and must have made significant practical contributions to the field of separation science that have helped advance the state of the art in the application of chromatography. Weight will be given to candidates who have taken a leadership role at their university, institute, or place of business.
SUBMISSION INSTRUCTIONS
You may nominate a colleague or yourself. Please e-mail the following items to Laura Bush, the editorial director of LCGC, at
lbush@advanstar.com
.
1. INFORMATION ABOUT THE PERSON YOU ARE NOMINATING
In a Word document, please provide the following information about the person you are nominating: - Full name - Organization - Current job title - Business address - Year highest degree was earned, and from where (institution and location) - Area(s) of focus of work - Key contributions to the field of separation science - Number of oral and poster presentations at scientific conferences - List/highlights of work as a journal reviewer - Key awards
2. CV AND LETTERS OF RECOMMENDATION
The nominee’s resume or CV must be submitted as a Word or PDF file, along with a minimum of two letters of recommendation from members of the separation science community with unrelated affiliations.
3. HEADSHOT
Include a high-resolution photo of the nominee in .JPG format
4. YOUR CONTACT INFORMATION
In the e-mail, list your name, organization, e-mail, and phone number. Questions about the submission process should be directed to Laura Bush, the editorial director of LCGC at
lbush@advanstar.com
. or +1 732.346.3020. Please note that this call for nominations is for the 2017 award. The winners of the 2016 LCGC Emerging Leader and Lifetime Achievement awards will be announced this fall and will be honored at an award symposium in the Pittcon 2016 technical program.
Presenting GC Data Comparisons to Laypersons to Understand Potential Courtroom Implications
January 6th 2025In forensic science, scientific testimony is routinely presented in court to juries who may have limited or no scientific background, putting law enforcement and defense personnel in the position of having to make rapid decisions in short timeframes based on findings of which they are not specialists. Katelynn Perrault Uptmor, Assistant Professor of Chemistry at William & Mary (Williamsburg, Virginia) believes that the introduction of new technologies into the framework of routine forensic analysis must therefore bridge the gap between introduction of new and novel analytical science and the communication of that science to a court of law, and that analytical chemistry research must be mindful of the need to fill this gap in promoting new technologies.
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
